PB2127: NO IMPACT OF STATIN USE ON RESPONSE AND SURVIVAL RATES IN NEWLY DIAGNOSED DLBCL PATIENTS TREATED WITH R-DA-EPOCH

por Sabljic, A., Sedinic, M., Kusec, R., Pejsa, V., Lucijanic, M.
Publicado 2022

P1110: EFFICACY AND SAFETY OF IMMUNOCHEMOTHERAPY IN TREATMENT OF FOLLICULAR NON-HODGKIN’S LYMPHOMA DURING COVID-19 PANDEMIC: A STUDY OF KROHEM, THE CROATIAN COOPERATIVE GROUP FOR H...

por Galusic, D., Basic - Kinda, S., Pijuk, A., Milunovic, V., Dreta, B., Franjic, N., Coha, B., Sincic – Petricevic, J., Gacina, P., Pejsa, V., Lucijanic, M., Aurer, I.
Publicado 2022

P1592: MATCHED CONTROL COMPARISON OF SURVIVAL OF HOSPITALIZED COVID-19 PATIENTS WITH HEMATOLOGICAL MALIGNANCIES, DATA FROM A LARGE TERTIARY CENTER REGISTRY

por Lucijanic, M., Soric, E., Sedinic, M., Sabljic, A., Tomasinec, S., Pasaric, A., Ivic, M., Vasilj, T., Cicic, D., Jonjic, Z., Pirsic, M., Mitrovic, Z., Prka, Z., Pejsa, V., Kusec, R., Jaksic, O.
Publicado 2022